2022 U.K. Cancer Diagnostics Market Shares-Competitive Analysis of Leading and Emerging Market Players
![](/report_cover/2215/2022-uk-cancer-diagnostics-market-shares-competitive-analysis-of-leading-n-emerging-market-players_en.gif)
This new report provides cancer diagnostics market shares.
The report analyzes current and emerging suppliers of cancer diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
The report analyzes current and emerging suppliers of cancer diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
COMPANY ASSESSMENTS
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic/Gen-Probe
Leica Biosystems/Kreatech
Ortho-Clinical Diagnostics/Carlyle Group
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic/Gen-Probe
Leica Biosystems/Kreatech
Ortho-Clinical Diagnostics/Carlyle Group
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.